These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 36184739)

  • 21. Exploring the potential of phytochemicals as inhibitors of 3'-phosphoadenosine 5'-phosphosulfate synthase 1 targeting cancer therapy.
    Alharbi B; Alharethi SH; Al-Soud WA; Ahmed Al-Keridis L; Aljohani AA; Jairajpuri DS; Alshammari N; Adnan M
    J Biomol Struct Dyn; 2024 Apr; 42(6):3193-3203. PubMed ID: 37184152
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictive insights into plant-based compounds as fibroblast growth factor receptor 1 inhibitors: a combined molecular docking and dynamics simulation study.
    Almoyad MAA; Wahab S; Ansari MN; Ahmad W; Hani U; Chandra S
    J Biomol Struct Dyn; 2024 Apr; ():1-10. PubMed ID: 38669200
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A multitier virtual screening study of phytoconstituents as Myeloid Cell Leukemias 1 inhibitors.
    Liu W; Khalid M; Wahab S; Faizan Siddiqui M; Hasan Khan S; Sadiq M; Khatoon Z
    J Biomol Struct Dyn; 2024 Jul; 42(10):5219-5228. PubMed ID: 37418235
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting Filamenting temperature-sensitive mutant Z (FtsZ) with bioactive phytoconstituents: An emerging strategy for antibacterial therapy.
    Alotaibi BS
    PLoS One; 2023; 18(8):e0290852. PubMed ID: 37647309
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A review on cyclin-dependent kinase 5: An emerging drug target for neurodegenerative diseases.
    Batra S; Jahan S; Ashraf A; Alharby B; Jawaid T; Islam A; Hassan I
    Int J Biol Macromol; 2023 Mar; 230():123259. PubMed ID: 36641018
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of mitogen-activated protein kinase 7 inhibitors from natural products: Combined virtual screening and dynamic simulation studies.
    Alharbi B; Alnajjar LI; Alhassan HH; Khan S; Jawaid T; Abdullaev BS; Alshammari N; Yadav DK; Adnan M; Shamsi A
    J Mol Recognit; 2024 Jan; 37(1):e3067. PubMed ID: 37956676
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuronal cyclin-dependent kinase 5: role in nervous system function and its specific inhibition by the Cdk5 inhibitory peptide.
    Kesavapany S; Li BS; Amin N; Zheng YL; Grant P; Pant HC
    Biochim Biophys Acta; 2004 Mar; 1697(1-2):143-53. PubMed ID: 15023357
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identifying bioactive phytoconstituents as C-terminal Src kinase inhibitors: a virtual screening and molecular simulation approach.
    Elfaki EM; Alhassan HH; Kamal M; Al-Enazi MM; Rub MA; Asiri AM; Ali M; Marwani HM; Alharethi SH; Alotaibi MM; Azum N
    J Biomol Struct Dyn; 2023; 41(22):13415-13424. PubMed ID: 36752377
    [TBL] [Abstract][Full Text] [Related]  

  • 29. p39 activates cdk5 in neurons, and is associated with the actin cytoskeleton.
    Humbert S; Dhavan R; Tsai L
    J Cell Sci; 2000 Mar; 113 ( Pt 6)():975-83. PubMed ID: 10683146
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An integrated docking and molecular dynamics simulation approach to discover potential inhibitors of activin receptor-like kinase 1.
    Jairajpuri DS; Mohammad T; Hussain A; Amir S; Fatima U; AlAjmi MF; Yadav DK; Hassan MI
    J Mol Recognit; 2024 Mar; 37(2):e3069. PubMed ID: 38053481
    [TBL] [Abstract][Full Text] [Related]  

  • 31. p39 Is Responsible for Increasing Cdk5 Activity during Postnatal Neuron Differentiation and Governs Neuronal Network Formation and Epileptic Responses.
    Li W; Allen ME; Rui Y; Ku L; Liu G; Bankston AN; Zheng JQ; Feng Y
    J Neurosci; 2016 Nov; 36(44):11283-11294. PubMed ID: 27807169
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discovering Tuberosin and Villosol as Potent and Selective Inhibitors of AKT1 for Therapeutic Targeting of Oral Squamous Cell Carcinoma.
    Adnan M; Jairajpuri DS; Chaddha M; Khan MS; Yadav DK; Mohammad T; Elasbali AM; Abu Al-Soud W; Hussain Alharethi S; Hassan MI
    J Pers Med; 2022 Jun; 12(7):. PubMed ID: 35887580
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The protein kinase Cdk5. Structural aspects, roles in neurogenesis and involvement in Alzheimer's pathology.
    Maccioni RB; Otth C; Concha II; Muñoz JP
    Eur J Biochem; 2001 Mar; 268(6):1518-27. PubMed ID: 11248668
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of high-affinity inhibitors of pyruvate dehydrogenase kinase-3: towards therapeutic management of cancer.
    Mohammad T; Arif K; Alajmi MF; Hussain A; Islam A; Rehman MT; Hassan I
    J Biomol Struct Dyn; 2021 Feb; 39(2):586-594. PubMed ID: 31903847
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structure-based virtual screening and molecular dynamics simulation for the identification of sphingosine kinase-2 inhibitors as potential analgesics.
    Akhilesh ; Baidya ATK; Uniyal A; Das B; Kumar R; Tiwari V
    J Biomol Struct Dyn; 2022; 40(23):12472-12490. PubMed ID: 34519252
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Searching for Novel Anaplastic Lymphoma Kinase Inhibitors: Structure-Guided Screening of Natural Compounds for a Tyrosine Kinase Therapeutic Target in Cancers.
    Adnan M; Koli S; Mohammad T; Siddiqui AJ; Patel M; Alshammari N; Bardakci F; Elasbali AM; Hassan MI
    OMICS; 2022 Aug; 26(8):461-470. PubMed ID: 35925819
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biological functions of CDK5 and potential CDK5 targeted clinical treatments.
    Shupp A; Casimiro MC; Pestell RG
    Oncotarget; 2017 Mar; 8(10):17373-17382. PubMed ID: 28077789
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Focusing on cyclin-dependent kinases 5: A potential target for neurological disorders.
    Tian Z; Feng B; Wang XQ; Tian J
    Front Mol Neurosci; 2022; 15():1030639. PubMed ID: 36438186
    [TBL] [Abstract][Full Text] [Related]  

  • 39. p39, the primary activator for cyclin-dependent kinase 5 (Cdk5) in oligodendroglia, is essential for oligodendroglia differentiation and myelin repair.
    Bankston AN; Li W; Zhang H; Ku L; Liu G; Papa F; Zhao L; Bibb JA; Cambi F; Tiwari-Woodruff SK; Feng Y
    J Biol Chem; 2013 Jun; 288(25):18047-57. PubMed ID: 23645679
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High throughput virtual screening and molecular dynamics simulation analysis of phytomolecules against BfmR of
    Lokhande KB; Pawar SV; Madkaiker S; Nawani N; Venkateswara SK; Ghosh P
    J Biomol Struct Dyn; 2023 Apr; 41(7):2698-2712. PubMed ID: 35156902
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.